Portfolio company
Autopoiesis
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
The company develops an artificial intelligence research partner that performs autonomous scientific discovery for researchers at academic institutions and pharmaceutical companies.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Drug Discovery
This company develops an artificial intelligence platform for automated molecular synthesis and drug discovery to assist pharmaceutical researchers in creating novel therapeutics.
ScienceMachine
This company develops autonomous artificial intelligence agents to automate biomedical data analysis and research workflows for biotechnology and pharmaceutical organisations.
Autoscience
This company develops autonomous artificial intelligence systems that automate machine learning research and model development for enterprise machine learning teams.
Capsule AI
This company develops autonomous agent systems that conduct scientific research and strategic analysis for pharmaceutical and biotechnology organisations.
N2TP
N2TP develops an artificial intelligence platform for scientific discovery, assisting researchers in the biomedicine and biotechnology sectors with hypothesis generation and experimental simulation.
Phylo
This company develops artificial intelligence agents and integrated software environments for researchers and life sciences organisations to automate biomedical research tasks.
Recursive
This company develops self-improving artificial intelligence systems designed to automate scientific discovery and research for the global technology and scientific communities.
Computational drug discovery platform
This company develops an AI-native platform for biologics discovery and engineering for biotechnology and pharmaceutical partners.
